INDP

Indaptus Therapeutics
$2.04
−$0.57 (−21.84%)Jul 27, 2026
2.0FairMoatMint rating

MoatMint rates Indaptus Therapeutics (INDP) 2.0 out of 10, a research rating of the company's quality, value, growth, momentum and financial health. Its quality rating is 1.1 out of 10.

Key metrics

The numbers that frame INDP today
Market cap
$231.01M
P/E (TTM)
-12.3
EV / FCF
-13.7
ROIC
929.9%
Div yield
0%
Debt / equity
0.0
52wk Low
$0.92
52wk High
$10.57

INDP stock rating

How INDP scores on quality, value, growth, momentum and financial health
2.0out of 10
Fair overallFair business, expensive priceTop 80% of ~5,000 US stocks
QualityPoor1.1/10
GrowthGreat10/10
MomentumFair3.3/10
ValueFair2.6/10
Financial HealthPoor0.8/10

Growth

Revenue and earnings trend for INDP
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about INDP
Is Indaptus Therapeutics a good buy?
No. Indaptus Therapeutics has poor quality and weak momentum. Both signals point to a weaker setup. Growth looks excellent, which supports the long-term business case, but that is not enough to offset the weak setup. We think Indaptus Therapeutics is selling at a high price.
What is the market capitalization of INDP?
Indaptus Therapeutics's market capitalization is $231.01M.
What is the P/E ratio for INDP stock?
Indaptus Therapeutics's current P/E ratio is -12.3.
What is the 52-week high for INDP stock?
The 52-week high for Indaptus Therapeutics is $10.57. The current close of $2.04 is 80.7% below that high.
What is the 52-week low for INDP stock?
The 52-week low for Indaptus Therapeutics is $0.92. The current close of $2.04 is 121.7% above that low.
Does INDP stock pay dividends?
Indaptus Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for INDP?
Indaptus Therapeutics's Debt / Equity ratio is 0.